-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IaYZNQFxHHuO6Z76QJ2k2uIWunXlO1H0h5UEwmMys71zXoBs550o6Prv/edmGKVt RT+ViohJc2wpjNTQWtgsyA== 0000200406-10-000098.txt : 20101025 0000200406-10-000098.hdr.sgml : 20101025 20101025155301 ACCESSION NUMBER: 0000200406-10-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101021 FILED AS OF DATE: 20101025 DATE AS OF CHANGE: 20101025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0209 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CULLEN JAMES CENTRAL INDEX KEY: 0001142630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 101139931 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD STREET 2: MS 1A-LC CITY: SANTA CLARA STATE: CA ZIP: 95051 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-10-21 0000200406 JOHNSON & JOHNSON JNJ 0001142630 CULLEN JAMES JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 0 0 0 Common 2010-10-21 4 S 0 15735 63.88 D 10423 D Common 2010-10-21 4 S 0 20000 63.88 D 0 I By Family LP and Family Foundation Phantom Stock Units Common 0 30443 D This transaction was executed in multiple trades at prices ranging from $63.54 to $64.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 745 shares held under Issuer's Dividend Reinvestment Plan. Also includes 135 shares held in reporting person's Fidelity dividend reinvestment plan, sold on October 21, 2010 in accordance with this report. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose. The Phantom Stock Units held under the Issuer's Non-Employee Director Deferred Fee Planare to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. 1 for 1 Linda E. King, Attorney in Fact for J. G. Cullen 2010-10-25 -----END PRIVACY-ENHANCED MESSAGE-----